Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies

Nadir Yehya1, Neal J Thomas2

  • 1Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania , Philadelphia, PA , USA.

Insights

Pediatric acute respiratory distress syndrome (PARDS) management needs better outcome measures than mortality. Research should explore alternatives to assess long-term recovery in children with PARDS.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Medicine
  • Clinical Trials Methodology

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) management often relies on adult data, despite differing epidemiology and outcomes.
  • Short-term mortality is a problematic primary outcome for PARDS trials due to lower rates and the influence of non-pulmonary factors.
  • Existing data on alternative outcome measures for PARDS are scarce, and proposed metrics like ventilator-free days may have biases.

Purpose of the Study:

  • To review challenges in defining outcomes for pediatric acute respiratory distress syndrome (PARDS) clinical trials.
  • To identify and suggest clinically relevant alternative outcome measures for PARDS research.
  • To guide future interventional studies and improve clinical practice for PARDS.

Main Methods:

  • Literature review of pediatric acute respiratory distress syndrome (PARDS) studies.
  • Analysis of outcome measures used in adult acute respiratory distress syndrome (ARDS) research.
  • Synthesis of findings to propose alternative outcome measures for PARDS.

Main Results:

  • Current PARDS research faces challenges in selecting appropriate outcome measures.
  • Adult ARDS survivor data highlight the importance of long-term functional and neuropsychiatric outcomes.
  • Ventilator-free days, a common alternative, may contain hidden biases.

Conclusions:

  • There is a critical need for validated, clinically relevant outcome measures beyond mortality in pediatric acute respiratory distress syndrome (PARDS) research.
  • Investigating long-term neurodevelopmental and functional outcomes is crucial for pediatric acute respiratory distress syndrome (PARDS) survivors.
  • Standardized outcome measures will facilitate robust clinical trials and enhance evidence-based management of pediatric acute respiratory distress syndrome (PARDS).

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
621
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
689
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.4K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.7K